Mesothelioma in the pleura, pericardium and peritoneum: Recommendations from the International Collaboration on Cancer Reporting (ICCR)
Aims Mesothelioma is a rare malignancy of the serosal membranes that is commonly related to exposure to asbestos. Despite extensive research and clinical trials, prognosis to date remains poor. Consistent, comprehensive and reproducible pathology reporting form the basis of all future interventions...
Gespeichert in:
| Veröffentlicht in: | Histopathology 2024-03, Vol.84 (4), p.633-645 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 645 |
|---|---|
| container_issue | 4 |
| container_start_page | 633 |
| container_title | Histopathology |
| container_volume | 84 |
| creator | Klebe, Sonja Judge, Meagan Brcic, Luka Dacic, Sanja Galateau‐Salle, Francoise Nicholson, Andrew G Roggli, Victor Nowak, Anna K Cooper, Wendy A |
| description | Aims
Mesothelioma is a rare malignancy of the serosal membranes that is commonly related to exposure to asbestos. Despite extensive research and clinical trials, prognosis to date remains poor. Consistent, comprehensive and reproducible pathology reporting form the basis of all future interventions for an individual patient, but also ensures that meaningful data are collected to identify predictive and prognostic markers.
Methods and results
This article details the International Collaboration on Cancer Reporting (ICCR) process and the development of the international consensus mesothelioma reporting data set. It describes the ‘core’ and ‘non‐core’ elements to be included in pathology reports for mesothelioma of all sites, inclusive of clinical, macroscopic, microscopic and ancillary testing considerations. An international expert panel consisting of pathologists and a medical oncologist produced a set of data items for biopsy and resection specimens based on a critical review and discussion of current evidence, and in light of the changes in the 2021 WHO Classification of Tumours. The commentary focuses particularly upon new entities such as mesothelioma in situ and provides background on relevant and essential ancillary testing as well as implementation of the new requirement for tumour grading.
Conclusion
We recommend widespread and consistent implementation of this data set, which will facilitate accurate reporting and enhance the consistency of data collection, improve the comparison of epidemiological data, support retrospective research and ultimately help to improve clinical outcomes. To this end, all data sets are freely available worldwide on the ICCR website (www.iccr‐cancer.org/data‐sets).
The International Collaboration on Cancer Reporting (ICCR) has developed an international consensus mesothelioma reporting data set which takes into account the recent updates to the WHO classification. |
| doi_str_mv | 10.1111/his.15106 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2897487859</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2922353719</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3486-893ab15c93fd449976d1d1cc5cc9016cc0724b10f5903f843de0f104aa230d8e3</originalsourceid><addsrcrecordid>eNp1kdFqFTEQhoNY7Gn1wheQgDctuG2ySXYT72Sp9kBFqHq95CSzNmWTrMku0ifwtU33tL0oOAQmE77_J8OP0FtKzmip8xuXz6igpHmBNpQ1oqqFUC_RhjCiKkKb9hAd5XxLCG1ZXb9Ch0wSziVXG_T3K-Q438DootfYBVzueBphSfoDniA5o5N1i8c62HWeY4DFf8TXYKL3EKyeXQwZDyn6VbwNM6SwvuoRd3Ec9S6mdcbldDoYSEU-xTS78AufbLvu-vQ1Ohj0mOHNQz9GPz9f_Oguq6tvX7bdp6vKMC6bSiqmd1QYxQbLuVJtY6mlxghjVFnUGNLWfEfJIBRhg-TMAhko4VrXjFgJ7Bid7H2nFH8vkOfeu2ygfDJAXHJfS9Vy2UqhCvr-GXobl7LZWChV10ywlt5Tp3vKpJhzgqGfkvM63fWU9Pfp9CWdfk2nsO8eHJedB_tEPsZRgPM98MeNcPd_p_5y-31v-Q-DBpmg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2922353719</pqid></control><display><type>article</type><title>Mesothelioma in the pleura, pericardium and peritoneum: Recommendations from the International Collaboration on Cancer Reporting (ICCR)</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Klebe, Sonja ; Judge, Meagan ; Brcic, Luka ; Dacic, Sanja ; Galateau‐Salle, Francoise ; Nicholson, Andrew G ; Roggli, Victor ; Nowak, Anna K ; Cooper, Wendy A</creator><creatorcontrib>Klebe, Sonja ; Judge, Meagan ; Brcic, Luka ; Dacic, Sanja ; Galateau‐Salle, Francoise ; Nicholson, Andrew G ; Roggli, Victor ; Nowak, Anna K ; Cooper, Wendy A</creatorcontrib><description>Aims
Mesothelioma is a rare malignancy of the serosal membranes that is commonly related to exposure to asbestos. Despite extensive research and clinical trials, prognosis to date remains poor. Consistent, comprehensive and reproducible pathology reporting form the basis of all future interventions for an individual patient, but also ensures that meaningful data are collected to identify predictive and prognostic markers.
Methods and results
This article details the International Collaboration on Cancer Reporting (ICCR) process and the development of the international consensus mesothelioma reporting data set. It describes the ‘core’ and ‘non‐core’ elements to be included in pathology reports for mesothelioma of all sites, inclusive of clinical, macroscopic, microscopic and ancillary testing considerations. An international expert panel consisting of pathologists and a medical oncologist produced a set of data items for biopsy and resection specimens based on a critical review and discussion of current evidence, and in light of the changes in the 2021 WHO Classification of Tumours. The commentary focuses particularly upon new entities such as mesothelioma in situ and provides background on relevant and essential ancillary testing as well as implementation of the new requirement for tumour grading.
Conclusion
We recommend widespread and consistent implementation of this data set, which will facilitate accurate reporting and enhance the consistency of data collection, improve the comparison of epidemiological data, support retrospective research and ultimately help to improve clinical outcomes. To this end, all data sets are freely available worldwide on the ICCR website (www.iccr‐cancer.org/data‐sets).
The International Collaboration on Cancer Reporting (ICCR) has developed an international consensus mesothelioma reporting data set which takes into account the recent updates to the WHO classification.</description><identifier>ISSN: 0309-0167</identifier><identifier>EISSN: 1365-2559</identifier><identifier>DOI: 10.1111/his.15106</identifier><identifier>PMID: 38044849</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Asbestos ; Biopsy ; Cancer ; check‐list ; Clinical trials ; Collaboration ; Data collection ; Epidemiology ; Humans ; Malignancy ; Mesothelioma ; Mesothelioma - diagnosis ; Mesothelioma, Malignant ; Pathology ; Pathology, Clinical - methods ; Pericardium ; Peritoneum ; Pleura ; protocol ; Retrospective Studies ; structured report ; synoptic report</subject><ispartof>Histopathology, 2024-03, Vol.84 (4), p.633-645</ispartof><rights>2023 The Authors. published by John Wiley & Sons Ltd.</rights><rights>2023 The Authors. Histopathology published by John Wiley & Sons Ltd.</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3486-893ab15c93fd449976d1d1cc5cc9016cc0724b10f5903f843de0f104aa230d8e3</cites><orcidid>0000-0001-8688-9178 ; 0000-0002-9098-8416 ; 0000-0003-3257-102X ; 0000-0002-8976-4714 ; 0000-0002-2814-1644 ; 0000-0001-5418-4229</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fhis.15106$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fhis.15106$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38044849$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Klebe, Sonja</creatorcontrib><creatorcontrib>Judge, Meagan</creatorcontrib><creatorcontrib>Brcic, Luka</creatorcontrib><creatorcontrib>Dacic, Sanja</creatorcontrib><creatorcontrib>Galateau‐Salle, Francoise</creatorcontrib><creatorcontrib>Nicholson, Andrew G</creatorcontrib><creatorcontrib>Roggli, Victor</creatorcontrib><creatorcontrib>Nowak, Anna K</creatorcontrib><creatorcontrib>Cooper, Wendy A</creatorcontrib><title>Mesothelioma in the pleura, pericardium and peritoneum: Recommendations from the International Collaboration on Cancer Reporting (ICCR)</title><title>Histopathology</title><addtitle>Histopathology</addtitle><description>Aims
Mesothelioma is a rare malignancy of the serosal membranes that is commonly related to exposure to asbestos. Despite extensive research and clinical trials, prognosis to date remains poor. Consistent, comprehensive and reproducible pathology reporting form the basis of all future interventions for an individual patient, but also ensures that meaningful data are collected to identify predictive and prognostic markers.
Methods and results
This article details the International Collaboration on Cancer Reporting (ICCR) process and the development of the international consensus mesothelioma reporting data set. It describes the ‘core’ and ‘non‐core’ elements to be included in pathology reports for mesothelioma of all sites, inclusive of clinical, macroscopic, microscopic and ancillary testing considerations. An international expert panel consisting of pathologists and a medical oncologist produced a set of data items for biopsy and resection specimens based on a critical review and discussion of current evidence, and in light of the changes in the 2021 WHO Classification of Tumours. The commentary focuses particularly upon new entities such as mesothelioma in situ and provides background on relevant and essential ancillary testing as well as implementation of the new requirement for tumour grading.
Conclusion
We recommend widespread and consistent implementation of this data set, which will facilitate accurate reporting and enhance the consistency of data collection, improve the comparison of epidemiological data, support retrospective research and ultimately help to improve clinical outcomes. To this end, all data sets are freely available worldwide on the ICCR website (www.iccr‐cancer.org/data‐sets).
The International Collaboration on Cancer Reporting (ICCR) has developed an international consensus mesothelioma reporting data set which takes into account the recent updates to the WHO classification.</description><subject>Asbestos</subject><subject>Biopsy</subject><subject>Cancer</subject><subject>check‐list</subject><subject>Clinical trials</subject><subject>Collaboration</subject><subject>Data collection</subject><subject>Epidemiology</subject><subject>Humans</subject><subject>Malignancy</subject><subject>Mesothelioma</subject><subject>Mesothelioma - diagnosis</subject><subject>Mesothelioma, Malignant</subject><subject>Pathology</subject><subject>Pathology, Clinical - methods</subject><subject>Pericardium</subject><subject>Peritoneum</subject><subject>Pleura</subject><subject>protocol</subject><subject>Retrospective Studies</subject><subject>structured report</subject><subject>synoptic report</subject><issn>0309-0167</issn><issn>1365-2559</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp1kdFqFTEQhoNY7Gn1wheQgDctuG2ySXYT72Sp9kBFqHq95CSzNmWTrMku0ifwtU33tL0oOAQmE77_J8OP0FtKzmip8xuXz6igpHmBNpQ1oqqFUC_RhjCiKkKb9hAd5XxLCG1ZXb9Ch0wSziVXG_T3K-Q438DootfYBVzueBphSfoDniA5o5N1i8c62HWeY4DFf8TXYKL3EKyeXQwZDyn6VbwNM6SwvuoRd3Ec9S6mdcbldDoYSEU-xTS78AufbLvu-vQ1Ohj0mOHNQz9GPz9f_Oguq6tvX7bdp6vKMC6bSiqmd1QYxQbLuVJtY6mlxghjVFnUGNLWfEfJIBRhg-TMAhko4VrXjFgJ7Bid7H2nFH8vkOfeu2ygfDJAXHJfS9Vy2UqhCvr-GXobl7LZWChV10ywlt5Tp3vKpJhzgqGfkvM63fWU9Pfp9CWdfk2nsO8eHJedB_tEPsZRgPM98MeNcPd_p_5y-31v-Q-DBpmg</recordid><startdate>202403</startdate><enddate>202403</enddate><creator>Klebe, Sonja</creator><creator>Judge, Meagan</creator><creator>Brcic, Luka</creator><creator>Dacic, Sanja</creator><creator>Galateau‐Salle, Francoise</creator><creator>Nicholson, Andrew G</creator><creator>Roggli, Victor</creator><creator>Nowak, Anna K</creator><creator>Cooper, Wendy A</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8688-9178</orcidid><orcidid>https://orcid.org/0000-0002-9098-8416</orcidid><orcidid>https://orcid.org/0000-0003-3257-102X</orcidid><orcidid>https://orcid.org/0000-0002-8976-4714</orcidid><orcidid>https://orcid.org/0000-0002-2814-1644</orcidid><orcidid>https://orcid.org/0000-0001-5418-4229</orcidid></search><sort><creationdate>202403</creationdate><title>Mesothelioma in the pleura, pericardium and peritoneum: Recommendations from the International Collaboration on Cancer Reporting (ICCR)</title><author>Klebe, Sonja ; Judge, Meagan ; Brcic, Luka ; Dacic, Sanja ; Galateau‐Salle, Francoise ; Nicholson, Andrew G ; Roggli, Victor ; Nowak, Anna K ; Cooper, Wendy A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3486-893ab15c93fd449976d1d1cc5cc9016cc0724b10f5903f843de0f104aa230d8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Asbestos</topic><topic>Biopsy</topic><topic>Cancer</topic><topic>check‐list</topic><topic>Clinical trials</topic><topic>Collaboration</topic><topic>Data collection</topic><topic>Epidemiology</topic><topic>Humans</topic><topic>Malignancy</topic><topic>Mesothelioma</topic><topic>Mesothelioma - diagnosis</topic><topic>Mesothelioma, Malignant</topic><topic>Pathology</topic><topic>Pathology, Clinical - methods</topic><topic>Pericardium</topic><topic>Peritoneum</topic><topic>Pleura</topic><topic>protocol</topic><topic>Retrospective Studies</topic><topic>structured report</topic><topic>synoptic report</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Klebe, Sonja</creatorcontrib><creatorcontrib>Judge, Meagan</creatorcontrib><creatorcontrib>Brcic, Luka</creatorcontrib><creatorcontrib>Dacic, Sanja</creatorcontrib><creatorcontrib>Galateau‐Salle, Francoise</creatorcontrib><creatorcontrib>Nicholson, Andrew G</creatorcontrib><creatorcontrib>Roggli, Victor</creatorcontrib><creatorcontrib>Nowak, Anna K</creatorcontrib><creatorcontrib>Cooper, Wendy A</creatorcontrib><collection>Wiley-Blackwell Open Access Titles</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Histopathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Klebe, Sonja</au><au>Judge, Meagan</au><au>Brcic, Luka</au><au>Dacic, Sanja</au><au>Galateau‐Salle, Francoise</au><au>Nicholson, Andrew G</au><au>Roggli, Victor</au><au>Nowak, Anna K</au><au>Cooper, Wendy A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mesothelioma in the pleura, pericardium and peritoneum: Recommendations from the International Collaboration on Cancer Reporting (ICCR)</atitle><jtitle>Histopathology</jtitle><addtitle>Histopathology</addtitle><date>2024-03</date><risdate>2024</risdate><volume>84</volume><issue>4</issue><spage>633</spage><epage>645</epage><pages>633-645</pages><issn>0309-0167</issn><eissn>1365-2559</eissn><abstract>Aims
Mesothelioma is a rare malignancy of the serosal membranes that is commonly related to exposure to asbestos. Despite extensive research and clinical trials, prognosis to date remains poor. Consistent, comprehensive and reproducible pathology reporting form the basis of all future interventions for an individual patient, but also ensures that meaningful data are collected to identify predictive and prognostic markers.
Methods and results
This article details the International Collaboration on Cancer Reporting (ICCR) process and the development of the international consensus mesothelioma reporting data set. It describes the ‘core’ and ‘non‐core’ elements to be included in pathology reports for mesothelioma of all sites, inclusive of clinical, macroscopic, microscopic and ancillary testing considerations. An international expert panel consisting of pathologists and a medical oncologist produced a set of data items for biopsy and resection specimens based on a critical review and discussion of current evidence, and in light of the changes in the 2021 WHO Classification of Tumours. The commentary focuses particularly upon new entities such as mesothelioma in situ and provides background on relevant and essential ancillary testing as well as implementation of the new requirement for tumour grading.
Conclusion
We recommend widespread and consistent implementation of this data set, which will facilitate accurate reporting and enhance the consistency of data collection, improve the comparison of epidemiological data, support retrospective research and ultimately help to improve clinical outcomes. To this end, all data sets are freely available worldwide on the ICCR website (www.iccr‐cancer.org/data‐sets).
The International Collaboration on Cancer Reporting (ICCR) has developed an international consensus mesothelioma reporting data set which takes into account the recent updates to the WHO classification.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>38044849</pmid><doi>10.1111/his.15106</doi><tpages>645</tpages><orcidid>https://orcid.org/0000-0001-8688-9178</orcidid><orcidid>https://orcid.org/0000-0002-9098-8416</orcidid><orcidid>https://orcid.org/0000-0003-3257-102X</orcidid><orcidid>https://orcid.org/0000-0002-8976-4714</orcidid><orcidid>https://orcid.org/0000-0002-2814-1644</orcidid><orcidid>https://orcid.org/0000-0001-5418-4229</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0309-0167 |
| ispartof | Histopathology, 2024-03, Vol.84 (4), p.633-645 |
| issn | 0309-0167 1365-2559 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2897487859 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Asbestos Biopsy Cancer check‐list Clinical trials Collaboration Data collection Epidemiology Humans Malignancy Mesothelioma Mesothelioma - diagnosis Mesothelioma, Malignant Pathology Pathology, Clinical - methods Pericardium Peritoneum Pleura protocol Retrospective Studies structured report synoptic report |
| title | Mesothelioma in the pleura, pericardium and peritoneum: Recommendations from the International Collaboration on Cancer Reporting (ICCR) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T23%3A01%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mesothelioma%20in%20the%20pleura,%20pericardium%20and%20peritoneum:%20Recommendations%20from%20the%20International%20Collaboration%20on%20Cancer%20Reporting%20(ICCR)&rft.jtitle=Histopathology&rft.au=Klebe,%20Sonja&rft.date=2024-03&rft.volume=84&rft.issue=4&rft.spage=633&rft.epage=645&rft.pages=633-645&rft.issn=0309-0167&rft.eissn=1365-2559&rft_id=info:doi/10.1111/his.15106&rft_dat=%3Cproquest_cross%3E2922353719%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2922353719&rft_id=info:pmid/38044849&rfr_iscdi=true |